- New treatment for invasive fungal infection candidiasis approved by FDA UC Davis Health
- Deadly fungus and companies with potential treatment Fox Business
- Cidara stock falls amid selloff in antifungal space (NASDAQ:CDTX) Seeking Alpha
- FDA Approves Long-Acting Antifungal for Treating Candida Medpage Today
- FDA signs off on Cidara’s antifungal Rezzayo for candidiasis FiercePharma
- View Full Coverage on Google News
Source link